

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of helicase activity (GO:0051095) | 4.86517860 |
| 2 | DNA deamination (GO:0045006) | 4.75339542 |
| 3 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.74183443 |
| 4 | negative regulation of telomerase activity (GO:0051974) | 4.43694709 |
| 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.14328464 |
| 6 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.14328464 |
| 7 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.10131683 |
| 8 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.04985109 |
| 9 | negative regulation of telomere maintenance (GO:0032205) | 4.02987401 |
| 10 | regulation of chemokine biosynthetic process (GO:0045073) | 4.01429834 |
| 11 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.99801289 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97175328 |
| 13 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.93993704 |
| 14 | termination of RNA polymerase III transcription (GO:0006386) | 3.93993704 |
| 15 | respiratory burst (GO:0045730) | 3.86852389 |
| 16 | cellular response to exogenous dsRNA (GO:0071360) | 3.77416838 |
| 17 | DNA damage response, detection of DNA damage (GO:0042769) | 3.74738292 |
| 18 | proteasome assembly (GO:0043248) | 3.65737613 |
| 19 | defense response to protozoan (GO:0042832) | 3.58829070 |
| 20 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52208269 |
| 21 | ribosome assembly (GO:0042255) | 3.48495380 |
| 22 | tRNA methylation (GO:0030488) | 3.46993783 |
| 23 | purine nucleobase biosynthetic process (GO:0009113) | 3.46954663 |
| 24 | pseudouridine synthesis (GO:0001522) | 3.38555616 |
| 25 | nucleobase biosynthetic process (GO:0046112) | 3.38410709 |
| 26 | mitotic metaphase plate congression (GO:0007080) | 3.34736377 |
| 27 | ribosome biogenesis (GO:0042254) | 3.27389797 |
| 28 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.25803986 |
| 29 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.20095217 |
| 30 | 7-methylguanosine mRNA capping (GO:0006370) | 3.16456796 |
| 31 | maturation of 5.8S rRNA (GO:0000460) | 3.15394492 |
| 32 | telomere maintenance via telomerase (GO:0007004) | 3.15380775 |
| 33 | endosome to melanosome transport (GO:0035646) | 3.09037054 |
| 34 | endosome to pigment granule transport (GO:0043485) | 3.09037054 |
| 35 | 7-methylguanosine RNA capping (GO:0009452) | 3.08041984 |
| 36 | RNA capping (GO:0036260) | 3.08041984 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.07594290 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06992094 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06992094 |
| 40 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06992094 |
| 41 | RNA-dependent DNA replication (GO:0006278) | 3.06556981 |
| 42 | telomere maintenance via telomere lengthening (GO:0010833) | 3.05322847 |
| 43 | NAD biosynthetic process (GO:0009435) | 3.04650780 |
| 44 | protein deneddylation (GO:0000338) | 3.03495795 |
| 45 | transcription from RNA polymerase I promoter (GO:0006360) | 3.02848394 |
| 46 | response to protozoan (GO:0001562) | 3.02799063 |
| 47 | IMP biosynthetic process (GO:0006188) | 3.02102967 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01486386 |
| 49 | DNA damage induced protein phosphorylation (GO:0006975) | 3.01199385 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.00753348 |
| 51 | DNA replication checkpoint (GO:0000076) | 3.00460820 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.98344452 |
| 53 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.98344452 |
| 54 | formation of translation preinitiation complex (GO:0001731) | 2.96448894 |
| 55 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95775803 |
| 56 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94613237 |
| 57 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94613237 |
| 58 | DNA replication initiation (GO:0006270) | 2.94611093 |
| 59 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.93309758 |
| 60 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.93150098 |
| 61 | rRNA modification (GO:0000154) | 2.92402928 |
| 62 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.89116880 |
| 63 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.89075472 |
| 64 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.88558331 |
| 65 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.87996554 |
| 66 | positive regulation of protein homodimerization activity (GO:0090073) | 2.87233068 |
| 67 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.86944547 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81700036 |
| 69 | protein maturation by protein folding (GO:0022417) | 2.81310766 |
| 70 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.80943109 |
| 71 | termination of RNA polymerase I transcription (GO:0006363) | 2.77348513 |
| 72 | mismatch repair (GO:0006298) | 2.76953001 |
| 73 | DNA strand elongation (GO:0022616) | 2.75784027 |
| 74 | regulation of telomerase activity (GO:0051972) | 2.74412009 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 2.73469908 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72551177 |
| 77 | positive regulation of humoral immune response (GO:0002922) | 2.71368193 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69810800 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 2.69810800 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69810800 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69810800 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69810800 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 2.69810800 |
| 84 | cellular response to dsRNA (GO:0071359) | 2.68741782 |
| 85 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68697887 |
| 86 | cullin deneddylation (GO:0010388) | 2.68263799 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.68032068 |
| 88 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.67306988 |
| 89 | negative regulation of ligase activity (GO:0051352) | 2.67306988 |
| 90 | regulation of protein heterodimerization activity (GO:0043497) | 2.66980838 |
| 91 | DNA-dependent DNA replication (GO:0006261) | 2.66101467 |
| 92 | sequestering of actin monomers (GO:0042989) | 2.65713055 |
| 93 | mitotic nuclear envelope disassembly (GO:0007077) | 2.63387338 |
| 94 | IMP metabolic process (GO:0046040) | 2.63268587 |
| 95 | L-methionine salvage (GO:0071267) | 2.63103608 |
| 96 | L-methionine biosynthetic process (GO:0071265) | 2.63103608 |
| 97 | amino acid salvage (GO:0043102) | 2.63103608 |
| 98 | RNA methylation (GO:0001510) | 2.62971561 |
| 99 | mitotic sister chromatid segregation (GO:0000070) | 2.62623763 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62505995 |
| 101 | ribosomal small subunit assembly (GO:0000028) | 2.61890789 |
| 102 | * tRNA processing (GO:0008033) | 2.61580120 |
| 103 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.61472324 |
| 104 | telomere maintenance via recombination (GO:0000722) | 2.61232689 |
| 105 | tRNA aminoacylation for protein translation (GO:0006418) | 2.60821639 |
| 106 | chromatin remodeling at centromere (GO:0031055) | 2.59538429 |
| 107 | CENP-A containing nucleosome assembly (GO:0034080) | 2.59454547 |
| 108 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.59322815 |
| 109 | rRNA methylation (GO:0031167) | 2.59024867 |
| 110 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.58446075 |
| 111 | * tRNA metabolic process (GO:0006399) | 2.57973214 |
| 112 | positive regulation of B cell differentiation (GO:0045579) | 2.57389357 |
| 113 | chaperone-mediated protein transport (GO:0072321) | 2.57272560 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.55924884 |
| 115 | metaphase plate congression (GO:0051310) | 2.55667362 |
| 116 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.55380875 |
| 117 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.54947843 |
| 118 | replication fork processing (GO:0031297) | 2.52314087 |
| 119 | tRNA aminoacylation (GO:0043039) | 2.52220892 |
| 120 | amino acid activation (GO:0043038) | 2.52220892 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51987065 |
| 122 | telomere maintenance (GO:0000723) | 2.51149612 |
| 123 | * tRNA modification (GO:0006400) | 2.50957835 |
| 124 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.50276792 |
| 125 | positive regulation of B cell mediated immunity (GO:0002714) | 2.50276792 |
| 126 | regulation of translation in response to stress (GO:0043555) | 2.50155287 |
| 127 | positive regulation of ligase activity (GO:0051351) | 2.50142458 |
| 128 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50078043 |
| 129 | telomere organization (GO:0032200) | 2.49725942 |
| 130 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.49432452 |
| 131 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.48253971 |
| 132 | B cell mediated immunity (GO:0019724) | 2.47971328 |
| 133 | methionine biosynthetic process (GO:0009086) | 2.47907364 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.47735571 |
| 135 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.47581509 |
| 136 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.47527824 |
| 137 | detection of bacterium (GO:0016045) | 2.47107841 |
| 138 | mitotic recombination (GO:0006312) | 2.46420760 |
| 139 | pentose metabolic process (GO:0019321) | 2.46293017 |
| 140 | spliceosomal snRNP assembly (GO:0000387) | 2.45683340 |
| 141 | protein targeting to mitochondrion (GO:0006626) | 2.45550864 |
| 142 | single strand break repair (GO:0000012) | 2.45184123 |
| 143 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.44679014 |
| 144 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.44679014 |
| 145 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.44498107 |
| 146 | negative regulation of metanephros development (GO:0072217) | 2.44030418 |
| 147 | histone arginine methylation (GO:0034969) | 2.43630638 |
| 148 | regulation of mitochondrial translation (GO:0070129) | 2.43343930 |
| 149 | pyrimidine-containing compound salvage (GO:0008655) | 2.43270657 |
| 150 | pyrimidine nucleoside salvage (GO:0043097) | 2.43270657 |
| 151 | peptidyl-arginine N-methylation (GO:0035246) | 2.42280611 |
| 152 | peptidyl-arginine methylation (GO:0018216) | 2.42280611 |
| 153 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.41472827 |
| 154 | DNA ligation (GO:0006266) | 2.41367970 |
| 155 | peptidyl-histidine modification (GO:0018202) | 2.40807215 |
| 156 | nuclear envelope disassembly (GO:0051081) | 2.40161518 |
| 157 | membrane disassembly (GO:0030397) | 2.40161518 |
| 158 | heterochromatin organization (GO:0070828) | 2.38995359 |
| 159 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38579679 |
| 160 | establishment of integrated proviral latency (GO:0075713) | 2.37723030 |
| 161 | negative regulation of chromosome segregation (GO:0051985) | 2.37418347 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.35972308 |
| 163 | mitotic spindle assembly checkpoint (GO:0007094) | 2.35689697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.31142510 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.36172512 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.79219204 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.73488523 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.64877712 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.13563057 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.05398118 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78824582 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77392743 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73326463 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.61549352 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60545422 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.56634263 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.55559357 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.51948064 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.49234030 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.48168700 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.48157596 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41811973 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33898455 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.33859148 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.28013280 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.23555374 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23455361 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18890782 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18875813 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13362832 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06115191 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.03984984 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01246444 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.99111358 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.95751684 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.94702960 |
| 34 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90410344 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.87424324 |
| 36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84446209 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.80034095 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.79570102 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79406091 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79137185 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.78154589 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77876543 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77647632 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.69052908 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68082782 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64468304 |
| 47 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64251314 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57580827 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.53720794 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53314028 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.52447702 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49471165 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48902841 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45672095 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44142321 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42907486 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42219868 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41957269 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41473375 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38344440 |
| 61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36188500 |
| 62 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34869640 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34112327 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32299704 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30693904 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30455628 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30036518 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29850962 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28706272 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26308294 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.25062884 |
| 72 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22283009 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19476756 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18228266 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17526313 |
| 76 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16781636 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.15554980 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14352262 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14159184 |
| 80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13136591 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.11758285 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11173748 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09215093 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09141277 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08309603 |
| 86 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08090401 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05328666 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03612547 |
| 89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03606721 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03067635 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02667876 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02478614 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02454094 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01117802 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98893846 |
| 96 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.96797645 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95562426 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95144733 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94127348 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.93369835 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92948511 |
| 102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92107530 |
| 103 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91440610 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90112523 |
| 105 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90092197 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89797909 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89362996 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.88582002 |
| 109 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.88042650 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87345076 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87203456 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86393760 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82724212 |
| 114 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.82064474 |
| 115 | MYB_26560356_Chip-Seq_TH1_Human | 0.81061801 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78910059 |
| 117 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77635008 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77570699 |
| 119 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.76614963 |
| 120 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.74268424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.05938848 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.74489141 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.43997069 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.09485378 |
| 5 | MP0009785_altered_susceptibility_to | 3.07709718 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.92848345 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.89032475 |
| 8 | MP0008058_abnormal_DNA_repair | 2.74662734 |
| 9 | MP0008057_abnormal_DNA_replication | 2.71295119 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.70533555 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.53767327 |
| 12 | MP0001873_stomach_inflammation | 2.23719848 |
| 13 | MP0001800_abnormal_humoral_immune | 2.21670589 |
| 14 | MP0003077_abnormal_cell_cycle | 2.18570162 |
| 15 | MP0001529_abnormal_vocalization | 2.17829201 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.16145382 |
| 17 | MP0003186_abnormal_redox_activity | 2.14059734 |
| 18 | MP0003303_peritoneal_inflammation | 1.99583267 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.99206422 |
| 20 | MP0005025_abnormal_response_to | 1.99034802 |
| 21 | MP0002398_abnormal_bone_marrow | 1.97237710 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.94818010 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.93635356 |
| 24 | MP0001819_abnormal_immune_cell | 1.92918023 |
| 25 | MP0001188_hyperpigmentation | 1.92887235 |
| 26 | MP0002723_abnormal_immune_serum | 1.91946762 |
| 27 | MP0001790_abnormal_immune_system | 1.87465058 |
| 28 | MP0005387_immune_system_phenotype | 1.87465058 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.85148546 |
| 30 | MP0005451_abnormal_body_composition | 1.83887131 |
| 31 | MP0002419_abnormal_innate_immunity | 1.82696320 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.78968622 |
| 33 | MP0001984_abnormal_olfaction | 1.73534291 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.71809283 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.71420925 |
| 36 | MP0000685_abnormal_immune_system | 1.71408515 |
| 37 | MP0002102_abnormal_ear_morphology | 1.70629857 |
| 38 | MP0006082_CNS_inflammation | 1.69659198 |
| 39 | MP0008260_abnormal_autophagy | 1.66714104 |
| 40 | MP0000716_abnormal_immune_system | 1.65888592 |
| 41 | MP0002163_abnormal_gland_morphology | 1.65691832 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.65629955 |
| 43 | MP0003787_abnormal_imprinting | 1.64680006 |
| 44 | MP0002722_abnormal_immune_system | 1.58630695 |
| 45 | MP0003718_maternal_effect | 1.53250399 |
| 46 | MP0000358_abnormal_cell_content/ | 1.51801740 |
| 47 | MP0004957_abnormal_blastocyst_morpholog | 1.50893244 |
| 48 | MP0002429_abnormal_blood_cell | 1.48599252 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.47506087 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.46537918 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.45903325 |
| 52 | MP0003724_increased_susceptibility_to | 1.45109138 |
| 53 | MP0002132_abnormal_respiratory_system | 1.44500954 |
| 54 | MP0003436_decreased_susceptibility_to | 1.41257244 |
| 55 | MP0005310_abnormal_salivary_gland | 1.41072186 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.39392493 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.39335840 |
| 58 | MP0004147_increased_porphyrin_level | 1.36613556 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.36008007 |
| 60 | MP0005410_abnormal_fertilization | 1.33627841 |
| 61 | MP0001730_embryonic_growth_arrest | 1.32128926 |
| 62 | MP0005670_abnormal_white_adipose | 1.32061183 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.30322770 |
| 64 | MP0002405_respiratory_system_inflammati | 1.30215616 |
| 65 | MP0009697_abnormal_copulation | 1.28868267 |
| 66 | MP0003786_premature_aging | 1.28524560 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.28369862 |
| 68 | MP0001764_abnormal_homeostasis | 1.28053856 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.26574877 |
| 70 | MP0008995_early_reproductive_senescence | 1.24433752 |
| 71 | MP0000350_abnormal_cell_proliferation | 1.19065940 |
| 72 | MP0010386_abnormal_urinary_bladder | 1.18112763 |
| 73 | MP0008932_abnormal_embryonic_tissue | 1.16167255 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.15981534 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.12902875 |
| 76 | MP0001853_heart_inflammation | 1.10396574 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.09539473 |
| 78 | MP0010307_abnormal_tumor_latency | 1.08535042 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.08114021 |
| 80 | MP0008469_abnormal_protein_level | 1.07513845 |
| 81 | MP0000490_abnormal_crypts_of | 1.04552962 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.99212548 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.99068377 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 0.97837981 |
| 85 | MP0001727_abnormal_embryo_implantation | 0.97039907 |
| 86 | MP0002080_prenatal_lethality | 0.96837551 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.95662483 |
| 88 | MP0009764_decreased_sensitivity_to | 0.92565087 |
| 89 | MP0000858_altered_metastatic_potential | 0.91076520 |
| 90 | MP0003866_abnormal_defecation | 0.90847253 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.90747670 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.90740062 |
| 93 | MP0005499_abnormal_olfactory_system | 0.89139482 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.89139482 |
| 95 | MP0001119_abnormal_female_reproductive | 0.88390651 |
| 96 | MP0008874_decreased_physiological_sensi | 0.88266314 |
| 97 | MP0000566_synostosis | 0.87716795 |
| 98 | MP0005389_reproductive_system_phenotype | 0.86532763 |
| 99 | MP0002210_abnormal_sex_determination | 0.84603428 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.84454954 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.83642763 |
| 102 | MP0001697_abnormal_embryo_size | 0.82860254 |
| 103 | MP0000313_abnormal_cell_death | 0.81760314 |
| 104 | MP0002933_joint_inflammation | 0.80706626 |
| 105 | MP0003011_delayed_dark_adaptation | 0.79736115 |
| 106 | MP0005384_cellular_phenotype | 0.79146229 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.79099784 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.78867602 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.77852944 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.77661985 |
| 111 | MP0000343_altered_response_to | 0.77431489 |
| 112 | MP0003448_altered_tumor_morphology | 0.76345272 |
| 113 | MP0002160_abnormal_reproductive_system | 0.75281269 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.74985552 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.73722861 |
| 116 | MP0000749_muscle_degeneration | 0.73435516 |
| 117 | MP0004883_abnormal_blood_vessel | 0.72907632 |
| 118 | MP0001905_abnormal_dopamine_level | 0.72524201 |
| 119 | MP0005380_embryogenesis_phenotype | 0.72466135 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.72466135 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.72403121 |
| 122 | MP0005330_cardiomyopathy | 0.70723122 |
| 123 | MP0009763_increased_sensitivity_to | 0.70636321 |
| 124 | MP0002653_abnormal_ependyma_morphology | 0.69443735 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.69224007 |
| 126 | MP0001919_abnormal_reproductive_system | 0.65594789 |
| 127 | MP0001145_abnormal_male_reproductive | 0.65576191 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.64202692 |
| 129 | MP0004133_heterotaxia | 0.64175349 |
| 130 | MP0001542_abnormal_bone_strength | 0.63807750 |
| 131 | MP0001929_abnormal_gametogenesis | 0.63719256 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.62248354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 2 muscle fiber atrophy (HP:0003554) | 5.00184677 |
| 2 | Muscle fiber atrophy (HP:0100295) | 4.47603679 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.30376359 |
| 4 | Increased serum pyruvate (HP:0003542) | 4.05898635 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 3.88502147 |
| 6 | Chromsome breakage (HP:0040012) | 3.87388374 |
| 7 | Abnormality of glycolysis (HP:0004366) | 3.83727066 |
| 8 | IgM deficiency (HP:0002850) | 3.77288877 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.71117449 |
| 10 | Hypokinesia (HP:0002375) | 3.47177161 |
| 11 | Ragged-red muscle fibers (HP:0003200) | 3.28729495 |
| 12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19477084 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.08340631 |
| 14 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.06498506 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05979142 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.01162369 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98408497 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98408497 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97028110 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97028110 |
| 21 | Obstructive lung disease (HP:0006536) | 2.95606631 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95606631 |
| 23 | Abnormality of the renal collecting system (HP:0004742) | 2.95523571 |
| 24 | Abnormality of the preputium (HP:0100587) | 2.94136708 |
| 25 | Duplicated collecting system (HP:0000081) | 2.88367470 |
| 26 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.82098341 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.78854493 |
| 28 | Agammaglobulinemia (HP:0004432) | 2.76119897 |
| 29 | Meckel diverticulum (HP:0002245) | 2.72468085 |
| 30 | Optic neuritis (HP:0100653) | 2.64982342 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.64982342 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.64612229 |
| 33 | Abnormality of the ileum (HP:0001549) | 2.62695716 |
| 34 | Progressive external ophthalmoplegia (HP:0000590) | 2.59471130 |
| 35 | Abnormality of T cells (HP:0002843) | 2.57627024 |
| 36 | Colitis (HP:0002583) | 2.57011004 |
| 37 | Myositis (HP:0100614) | 2.51497481 |
| 38 | Recurrent viral infections (HP:0004429) | 2.51386354 |
| 39 | Abnormality of chromosome stability (HP:0003220) | 2.51346822 |
| 40 | Neutropenia (HP:0001875) | 2.49558028 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.49033649 |
| 42 | Abnormal gallbladder physiology (HP:0012438) | 2.48041755 |
| 43 | Cholecystitis (HP:0001082) | 2.48041755 |
| 44 | Abnormality of DNA repair (HP:0003254) | 2.47797720 |
| 45 | Increased IgM level (HP:0003496) | 2.47696926 |
| 46 | Amniotic constriction ring (HP:0009775) | 2.46664418 |
| 47 | Abnormality of placental membranes (HP:0011409) | 2.46664418 |
| 48 | Microvesicular hepatic steatosis (HP:0001414) | 2.45140855 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.43372462 |
| 50 | Squamous cell carcinoma (HP:0002860) | 2.42769967 |
| 51 | Encephalitis (HP:0002383) | 2.41230103 |
| 52 | Aplastic anemia (HP:0001915) | 2.40869050 |
| 53 | Bone marrow hypocellularity (HP:0005528) | 2.40098023 |
| 54 | Amaurosis fugax (HP:0100576) | 2.39914619 |
| 55 | IgG deficiency (HP:0004315) | 2.38602625 |
| 56 | Esophageal atresia (HP:0002032) | 2.38390320 |
| 57 | Hepatic necrosis (HP:0002605) | 2.36506302 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.34809747 |
| 59 | Clubbing of toes (HP:0100760) | 2.34580491 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.33797002 |
| 61 | Alveolar cell carcinoma (HP:0006519) | 2.32577509 |
| 62 | Lymphoma (HP:0002665) | 2.29478772 |
| 63 | Prolonged neonatal jaundice (HP:0006579) | 2.28325615 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27491596 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.27141445 |
| 66 | Pancytopenia (HP:0001876) | 2.22739824 |
| 67 | Cellular immunodeficiency (HP:0005374) | 2.22460933 |
| 68 | Meningitis (HP:0001287) | 2.21530314 |
| 69 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.19259192 |
| 70 | Orchitis (HP:0100796) | 2.19190469 |
| 71 | Recurrent sinusitis (HP:0011108) | 2.18817044 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.18736601 |
| 73 | Respiratory difficulties (HP:0002880) | 2.18155866 |
| 74 | Cerebral hypomyelination (HP:0006808) | 2.17879598 |
| 75 | Rough bone trabeculation (HP:0100670) | 2.17015569 |
| 76 | Abnormal protein glycosylation (HP:0012346) | 2.16532632 |
| 77 | Abnormal glycosylation (HP:0012345) | 2.16532632 |
| 78 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.16532632 |
| 79 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.16532632 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15396684 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.14735992 |
| 82 | Leukopenia (HP:0001882) | 2.14013271 |
| 83 | Stomatitis (HP:0010280) | 2.12729583 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.12237910 |
| 85 | Prostate neoplasm (HP:0100787) | 2.12106162 |
| 86 | Myelodysplasia (HP:0002863) | 2.11990904 |
| 87 | Urticaria (HP:0001025) | 2.11889273 |
| 88 | Pancreatic cysts (HP:0001737) | 2.08115359 |
| 89 | Increased serum lactate (HP:0002151) | 2.06234746 |
| 90 | Anorexia (HP:0002039) | 2.06223326 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06180106 |
| 92 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.05426519 |
| 93 | Lactic acidosis (HP:0003128) | 2.03800424 |
| 94 | Hepatocellular necrosis (HP:0001404) | 2.03643184 |
| 95 | Chronic diarrhea (HP:0002028) | 2.02833349 |
| 96 | Hypomagnesemia (HP:0002917) | 2.02485101 |
| 97 | True hermaphroditism (HP:0010459) | 2.01283828 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 2.00408618 |
| 99 | Abnormality of magnesium homeostasis (HP:0004921) | 2.00268954 |
| 100 | Carpal bone hypoplasia (HP:0001498) | 2.00071371 |
| 101 | Increased connective tissue (HP:0009025) | 1.99893078 |
| 102 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99414755 |
| 103 | Progressive muscle weakness (HP:0003323) | 1.99170194 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 1.97106564 |
| 105 | Cutaneous melanoma (HP:0012056) | 1.96339860 |
| 106 | Granulocytopenia (HP:0001913) | 1.95517500 |
| 107 | Mitochondrial inheritance (HP:0001427) | 1.95140239 |
| 108 | IgA deficiency (HP:0002720) | 1.95113589 |
| 109 | Basal cell carcinoma (HP:0002671) | 1.95100806 |
| 110 | Pustule (HP:0200039) | 1.94585544 |
| 111 | Mediastinal lymphadenopathy (HP:0100721) | 1.94119426 |
| 112 | Recurrent skin infections (HP:0001581) | 1.93777243 |
| 113 | Multiple enchondromatosis (HP:0005701) | 1.92785594 |
| 114 | Lymphopenia (HP:0001888) | 1.92336010 |
| 115 | Cellulitis (HP:0100658) | 1.91195526 |
| 116 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90613695 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.89602053 |
| 118 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87580709 |
| 119 | Progressive macrocephaly (HP:0004481) | 1.87450458 |
| 120 | Duodenal stenosis (HP:0100867) | 1.86941916 |
| 121 | Small intestinal stenosis (HP:0012848) | 1.86941916 |
| 122 | Oral leukoplakia (HP:0002745) | 1.86354967 |
| 123 | Acute encephalopathy (HP:0006846) | 1.85892940 |
| 124 | Vasculitis (HP:0002633) | 1.82992661 |
| 125 | Increased CSF lactate (HP:0002490) | 1.82858791 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82729379 |
| 127 | Abnormality of macrophages (HP:0004311) | 1.80215840 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.80058220 |
| 129 | B lymphocytopenia (HP:0010976) | 1.80058220 |
| 130 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79862714 |
| 131 | Petechiae (HP:0000967) | 1.79656967 |
| 132 | Inflammation of the large intestine (HP:0002037) | 1.79586173 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.76156409 |
| 134 | T lymphocytopenia (HP:0005403) | 1.75690187 |
| 135 | Degeneration of anterior horn cells (HP:0002398) | 1.73722281 |
| 136 | Abnormality of the anterior horn cell (HP:0006802) | 1.73722281 |
| 137 | Optic nerve coloboma (HP:0000588) | 1.73543883 |
| 138 | Absent radius (HP:0003974) | 1.72634685 |
| 139 | Pancreatic fibrosis (HP:0100732) | 1.72460273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.00692275 |
| 2 | STK16 | 3.48272350 |
| 3 | IRAK3 | 3.13513747 |
| 4 | ZAK | 3.05635292 |
| 5 | EIF2AK3 | 2.71651322 |
| 6 | MAP3K5 | 2.60192380 |
| 7 | PLK4 | 2.57604946 |
| 8 | TAOK2 | 2.48529630 |
| 9 | MAP4K1 | 2.42392609 |
| 10 | IRAK4 | 2.41461299 |
| 11 | BUB1 | 2.41002656 |
| 12 | TAOK3 | 2.31532309 |
| 13 | RIPK4 | 2.26691810 |
| 14 | EIF2AK1 | 2.15848533 |
| 15 | MAP3K12 | 2.10478775 |
| 16 | TSSK6 | 2.06307668 |
| 17 | VRK2 | 2.02713037 |
| 18 | MAP3K14 | 2.02430284 |
| 19 | SMG1 | 1.85460327 |
| 20 | PIK3CA | 1.73770918 |
| 21 | SRPK1 | 1.65848500 |
| 22 | WEE1 | 1.65794587 |
| 23 | NME2 | 1.65151941 |
| 24 | CDC7 | 1.64329119 |
| 25 | MAP4K2 | 1.62120276 |
| 26 | NEK1 | 1.51747982 |
| 27 | TESK2 | 1.51504524 |
| 28 | CASK | 1.50974209 |
| 29 | MAP3K11 | 1.49793628 |
| 30 | FES | 1.47258565 |
| 31 | VRK1 | 1.46715908 |
| 32 | CDK19 | 1.41713303 |
| 33 | PBK | 1.39303536 |
| 34 | ZAP70 | 1.37822704 |
| 35 | JAK3 | 1.36462216 |
| 36 | TIE1 | 1.34700188 |
| 37 | BMPR2 | 1.33779027 |
| 38 | SIK2 | 1.31660588 |
| 39 | BLK | 1.31645533 |
| 40 | CCNB1 | 1.30061678 |
| 41 | IKBKE | 1.25915807 |
| 42 | NEK9 | 1.24780720 |
| 43 | EIF2AK2 | 1.21623858 |
| 44 | MAP2K6 | 1.20269273 |
| 45 | MAP2K3 | 1.19665202 |
| 46 | BCKDK | 1.18948241 |
| 47 | GRK6 | 1.15388447 |
| 48 | INSRR | 1.14483502 |
| 49 | YES1 | 1.12522383 |
| 50 | MAP2K7 | 1.12398950 |
| 51 | PRPF4B | 1.11743165 |
| 52 | TTK | 1.11324988 |
| 53 | PIM2 | 1.11117668 |
| 54 | SYK | 1.11079022 |
| 55 | TESK1 | 1.10484500 |
| 56 | MUSK | 1.06829149 |
| 57 | ATR | 1.05610395 |
| 58 | MARK3 | 1.02741687 |
| 59 | TLK1 | 1.01026130 |
| 60 | TNK2 | 1.00234733 |
| 61 | CSK | 1.00011076 |
| 62 | AKT3 | 0.99963079 |
| 63 | PASK | 0.98645597 |
| 64 | ARAF | 0.98097170 |
| 65 | FGFR4 | 0.95721421 |
| 66 | STK4 | 0.95146683 |
| 67 | MKNK2 | 0.93887829 |
| 68 | PLK3 | 0.93239891 |
| 69 | IKBKB | 0.91961684 |
| 70 | MST1R | 0.91535999 |
| 71 | NEK6 | 0.91411934 |
| 72 | ACVR1B | 0.89624084 |
| 73 | PLK1 | 0.88244155 |
| 74 | KIT | 0.85413429 |
| 75 | CSNK1G3 | 0.85143770 |
| 76 | TBK1 | 0.83624340 |
| 77 | PDK2 | 0.82507417 |
| 78 | FGR | 0.82380453 |
| 79 | BTK | 0.82219359 |
| 80 | MKNK1 | 0.80514000 |
| 81 | ADRBK2 | 0.79815538 |
| 82 | NME1 | 0.79144728 |
| 83 | LYN | 0.78777987 |
| 84 | SGK2 | 0.76499285 |
| 85 | ERN1 | 0.74604303 |
| 86 | PINK1 | 0.72916506 |
| 87 | RPS6KA5 | 0.72557650 |
| 88 | IRAK1 | 0.71881137 |
| 89 | SIK3 | 0.68942981 |
| 90 | CHEK2 | 0.67653167 |
| 91 | CDC42BPA | 0.67196143 |
| 92 | LCK | 0.66501669 |
| 93 | AURKB | 0.64302474 |
| 94 | IRAK2 | 0.64033426 |
| 95 | TEC | 0.62192058 |
| 96 | TAF1 | 0.61026525 |
| 97 | PAK4 | 0.60993086 |
| 98 | CDK3 | 0.59690786 |
| 99 | ITK | 0.59633022 |
| 100 | STK24 | 0.58761908 |
| 101 | PIM1 | 0.58066341 |
| 102 | EPHB1 | 0.56739750 |
| 103 | MAP3K8 | 0.56398742 |
| 104 | BRSK2 | 0.53186983 |
| 105 | TYK2 | 0.53024164 |
| 106 | HCK | 0.50657651 |
| 107 | NUAK1 | 0.50547881 |
| 108 | MAPKAPK5 | 0.49349870 |
| 109 | TGFBR1 | 0.49297414 |
| 110 | BRSK1 | 0.49199024 |
| 111 | STK38L | 0.47230855 |
| 112 | AURKA | 0.45779276 |
| 113 | CSNK1A1L | 0.45492508 |
| 114 | DAPK1 | 0.44766950 |
| 115 | CHEK1 | 0.43598228 |
| 116 | PDK3 | 0.43417160 |
| 117 | PDK4 | 0.43417160 |
| 118 | CSNK2A1 | 0.42603663 |
| 119 | TRIM28 | 0.39809185 |
| 120 | CSF1R | 0.39483220 |
| 121 | CSNK1G2 | 0.39007178 |
| 122 | MAP3K3 | 0.38774687 |
| 123 | MAP3K1 | 0.38094156 |
| 124 | CDK7 | 0.37874071 |
| 125 | CHUK | 0.37784476 |
| 126 | NLK | 0.37500595 |
| 127 | MAPK11 | 0.36825697 |
| 128 | SCYL2 | 0.35754337 |
| 129 | PRKCQ | 0.35735722 |
| 130 | CSNK1G1 | 0.35732858 |
| 131 | PAK1 | 0.35716100 |
| 132 | TAOK1 | 0.35570652 |
| 133 | NEK2 | 0.35229344 |
| 134 | MELK | 0.34915927 |
| 135 | DYRK3 | 0.33611371 |
| 136 | RPS6KA4 | 0.33277636 |
| 137 | DAPK3 | 0.31884092 |
| 138 | PLK2 | 0.31792254 |
| 139 | KDR | 0.31752942 |
| 140 | DYRK2 | 0.31304966 |
| 141 | ATM | 0.31293055 |
| 142 | CSNK2A2 | 0.31231534 |
| 143 | STK10 | 0.31145484 |
| 144 | GRK7 | 0.30960041 |
| 145 | LIMK1 | 0.30788443 |
| 146 | RPS6KB1 | 0.30651339 |
| 147 | SGK3 | 0.30538791 |
| 148 | RAF1 | 0.29904362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.23334389 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.66751033 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.07819676 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.03152306 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.99980302 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.60286390 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58940280 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.48489845 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.47690877 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.47043225 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43477190 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.42398899 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.32405414 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.17704228 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.04246661 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 2.00926207 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00429731 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95953753 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.74823802 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72311731 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.70406985 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68975785 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61532702 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.58845807 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.53863901 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.50764110 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48083309 |
| 28 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.46619034 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.43974324 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42217208 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41417732 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38590614 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.37845007 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31466007 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30807595 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30150180 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29866501 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27430716 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21894472 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13514010 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10438163 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08870206 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08073172 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07434810 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02451715 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.00862476 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97635224 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 0.94283589 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92527816 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92459631 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89669180 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88491873 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87911098 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87834425 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87124200 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85979583 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85871802 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.85740788 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83993477 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82883872 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82812471 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.80602027 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77914204 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77671001 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76607210 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74117300 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.72139638 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72125044 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71910330 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70346934 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70233565 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.69520448 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68018969 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67078480 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65942043 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.63161893 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63116700 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55596983 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54324945 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53385776 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53097479 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52912601 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52434550 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51402680 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51328059 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50077211 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.48232367 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47913364 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46968610 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44535273 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44442152 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44153530 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44068805 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43209230 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.42862016 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42181548 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39047247 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37277342 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36444801 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34285988 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34244251 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.33570835 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33203245 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32838407 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32524942 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29132573 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28878597 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27915903 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26568771 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.26038966 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26032812 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25814969 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25190667 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.25167601 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24372770 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24286512 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23567221 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22386065 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.19081384 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.19046223 |
| 121 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18994130 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18967478 |

